ViVitro Labs will highlight the ViViFlow Electromagnetic Flow Meter and ViVitro Endovascular Simulator for cardiovascular devices on October 28 – November 2, in booth 2256 at TCT in Washington DC. Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine.
In addition to the new products, ViVitro’s Latin American sales representative, Críons Development Manager, Andreluiz de Sousa Cunha, will join ViVitro in the company booth.
- stent grafts
- transcatheter heart valves
- Improved performance (accuracy and flow measuring range)
- Reduced susceptibility to noise and drift
- Increased reliability
- Easier calibration and faster start-up time
- Support for two flow probes
ViVitro team members at the show include: GM Gerry Wight, North American Major Accounts Manager Douglas Bigrigg, Customer Support Trainer Mike Harding and Laboratory Technician Marshall Kilduff. They will be on hand to demonstrate the products and answer any questions. Latin American sales representative, Críons Development Manager, Andreluiz de Sousa Cunha, will join the team. Marshall and Andreluiz are attending TCT for the first time. All of the team members are happy to set up private meetings at the show and can be contacted at email@example.com to arrange an appointment.
About ViVitro Labs
ViVitro Labs Inc. offers industry-leading cardiovascular test equipment and related laboratory testing and consulting services. Hundreds of organizations in over 40 countries for 30 years have trusted ViVitro expertise, accuracy, and quality for their heart valve, LVAD, TAH, stent, and graft testing. ViVitro Laboratory Services holds ISO/IEC 17025 accreditation based on ISO 5840. ViVitro products are manufactured by StarFish Medical. ViVitro’s A2LA Scope of Accreditation includes the physical and mechanical testing of heart valve substitutes.
For more information please contact:
# # #